# OnCo record rejuv-life-money-after-treatment (technology). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/technologies/rejuv-life-money-after-treatment/>
  a schema:MedicalTherapy ;
  onco:kind "technology" ;
  schema:identifier "rejuv-life-money-after-treatment" ;
  schema:name "Money after treatment: what the cost of cancer does once the treatment has finished"@en ;
  schema:description "In a United States cohort covering 231,596 people diagnosed between 1995 and 2009, those who filed for bankruptcy after a cancer diagnosis had a mortality hazard ratio of 1.79 against propensity-matched people who did not. In a national survey of people over 50, 42.4 per cent had depleted their entire assets two years after diagnosis, losing an average of 92,098 dollars."@en ;
  schema:url <https://onco.cc/technologies/rejuv-life-money-after-treatment/> ;
  schema:dateModified "2026-10-02"^^xsd:date ;
  schema:sameAs <https://en.wikipedia.org/wiki/Financial_toxicity> ;
  schema:citation <https://doi.org/10.1377/hlthaff.2012.1263>, <https://doi.org/10.1200/JCO.2015.64.6620>, <https://doi.org/10.1016/j.amjmed.2018.05.020>, <https://doi.org/10.1016/j.esmoop.2025.105767> ;
  onco:status "established" ;
  onco:tag "rejuvenation", "survivorship", "evidence:moderate", "psychosocial", "equity" ;
  onco:related <https://onco.cc/ideas/idea-moon-financial-toxicity-screening/>, <https://onco.cc/ideas/idea-cost-financial-toxicity-screening/>, <https://onco.cc/ideas/idea-reg-financial-toxicity-vital-sign/>, <https://onco.cc/ideas/idea-acc-financial-toxicity-screening-at-diagnosis/> ;
  onco:cancers <https://onco.cc/cancers/colorectal/>, <https://onco.cc/cancers/prostate/>, <https://onco.cc/cancers/thyroid/>, <https://onco.cc/cancers/breast-hr-positive/>, <https://onco.cc/cancers/multiple-myeloma/>, <https://onco.cc/cancers/nsclc/> ;
  onco:sections <https://onco.cc/fronts/rejuvenation/>, <https://onco.cc/fronts/supportive-care/> ;
  onco:technologies <https://onco.cc/technologies/financial-navigation/>, <https://onco.cc/technologies/rejuv-life-return-to-work/>, <https://onco.cc/technologies/rejuv-life-employment-rights-uk/>, <https://onco.cc/technologies/rejuv-life-employment-rights-us/>, <https://onco.cc/technologies/rejuv-life-insurance-loans-and-the-right-to-be-forgotten/>, <https://onco.cc/technologies/rejuv-mind-distress-screening/>, <https://onco.cc/technologies/survivorship-care-plan/> ;
  onco:terms <https://onco.cc/terms/financial-toxicity/>, <https://onco.cc/terms/work-and-money-breast-cancer-uk/>, <https://onco.cc/terms/quality-of-life/> ;
  onco:bottlenecks <https://onco.cc/bottlenecks/b-survivorship/>, <https://onco.cc/bottlenecks/b-drug-pricing/>, <https://onco.cc/bottlenecks/b-global-access/> .